LEADERSHIP Newspaper8h
10 Firms Close Shop Over Nigeria’s Harsh Economy In 1 Year
No fewer than 10 companies have shut down or relocated their operations from Nigeria due to the current economic challenges, ...
The Pharma Letter29m
The week in pharma: action, reaction and insight – week to November 15
Last week saw US pharma major AbbVie release disappointing Phase II trial results on its emraclidine in schizophrenia, which ...
The Pharma Letter20h
Gilead’s Livdelzi reduced pruritus severity in PBC participants
US antiviral giant Gilead Sciences on Friday unveiled two-and-a-half-year interim analysis from the ongoing Phase III ASSURE ...